MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial

Autor: Timmer, Florentine E F *, *, Geboers, Bart *, Ruarus, Alette H, Vroomen, Laurien G P H, Schouten, Evelien A C, van der Lei, Susan, Vos, Danielle J W, Dijkstra, Madelon, Schulz, Hannah H, Bakker, Joyce, van den Bemd, Bente A T, van den Tol, Petrousjka M, Puijk, Robbert S, Lissenberg-Witte, Birgit I, de Gruijl, Tanja D, de Vries, Jan J J, Lagerwaard, Frank J, Scheffer, Hester J, Bruynzeel, Anna M E, Meijerink, Martijn R
Zdroj: In The Lancet Gastroenterology & Hepatology May 2024 9(5):448-459
Databáze: ScienceDirect